Dustin Freas
Direktor/Vorstandsmitglied bei Brytemap, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Bryan Lopez | M | - |
Brytemap, Inc.
 Brytemap, Inc. Packaged SoftwareTechnology Services Brytemap, Inc. develops seed-to-sale cannabis compliance software. The company was founded by Bryan Lopez in 2016 and is headquartered in Hunt Valley, MD. | 8 Jahre |
| Justin Molignoni | M | - |
RS Biotherapeutics, Inc.
 RS Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology RS Biotherapeutics, Inc. engages in the research and development of drugs for chronic and acute pulmonary inflammation diseases. The company is based in Cumberland, MD. Dean Hart has been the CEO of the company since 2023. | - |
| Colin Kelley | M | - |
Brytemap, Inc.
Brytemap, Inc. Packaged SoftwareTechnology Services Brytemap, Inc. develops seed-to-sale cannabis compliance software. The company was founded by Bryan Lopez in 2016 and is headquartered in Hunt Valley, MD. | - |
| Dean Hart | M | - |
RS Biotherapeutics, Inc.
RS Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology RS Biotherapeutics, Inc. engages in the research and development of drugs for chronic and acute pulmonary inflammation diseases. The company is based in Cumberland, MD. Dean Hart has been the CEO of the company since 2023. | 1 Jahre |
| Jeffrey Scott Denholm | M | - |
Brytemap, Inc.
Brytemap, Inc. Packaged SoftwareTechnology Services Brytemap, Inc. develops seed-to-sale cannabis compliance software. The company was founded by Bryan Lopez in 2016 and is headquartered in Hunt Valley, MD. | - |
| Todd Gargano | M | - |
Brytemap, Inc.
Brytemap, Inc. Packaged SoftwareTechnology Services Brytemap, Inc. develops seed-to-sale cannabis compliance software. The company was founded by Bryan Lopez in 2016 and is headquartered in Hunt Valley, MD. | - |
| David Freas | M | - |
RS Biotherapeutics, Inc.
RS Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology RS Biotherapeutics, Inc. engages in the research and development of drugs for chronic and acute pulmonary inflammation diseases. The company is based in Cumberland, MD. Dean Hart has been the CEO of the company since 2023. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 7 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Dustin Freas
- Persönliches Netzwerk
